BioNexus Gene Lab
BGLC
$0.42
Share price
-3.48%
Change (1 day)
63.38%
Change (1 year)
Categories
BioNexus Gene Lab (BGLC) - P/B ratio
P/B ratio as of June 2024 : 0.9263
According to BioNexus Gene Lab's latest financial reports the company has a price-to-book ratio of 0.9263.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
BioNexus Gene Lab - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.9696 | -96.08% |
| 2022-12-31 | 24.8 | -51.25% |
| 2021-12-31 | 50.8 | 43.22% |
| 2020-12-31 | 35.5 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | 97.78% | 🇺🇸 USA |